About this episode

This episode discusses how clinical diagnostics are enhancing personalized care in medicine.

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D. , president and CEO of Mayo Clinic Laboratories, to discuss recent industry news and how clinical diagnostics are powering more personalized care. Together, they explore: Point-of-care testing in outbreak response (00:29): Hear about the potential and limitations of point-of-care testing during disease outbreaks. A rare type of Lyme disease (02:46) : Learn about the spread of the second known pathogen to cause Lyme disease in the U.S. The evolution of AI (04:50) : Dr. Morice shares insights from a recent conference, highlighting the shift from discussing artificial intelligence’s potential to scaling real-world clinical applications. Personalized medicine and diagnostics (06:07) : Discover how clinical diagnostics are driving personalized medicine and how data will shape its future. Resources Four ways diagnostics are driving more personalized care "Answers From the Lab" podcast: Advancing Precision Medicine Through Therapeutic Tests "Answers From the Lab" podcast: Risks Increase as Ticks, Mosquitoes, and…

People in this episode

Host: Bobbi Pritt, M.D.

Guest: William Morice II, M.D., Ph.D.

Topics covered

• personalized therapy
• clinical diagnostics
• point-of-care testing
• Lyme disease
• artificial intelligence
• personalized medicine

Keywords

• personalized therapy
• clinical diagnostics
• point-of-care testing
• Lyme disease
• artificial intelligence
• personalized medicine

Mentioned in this episode

Organizations: Mayo Clinic, Mayo Clinic Laboratories

More episodes of Answers from the Lab

• Lab Outreach Delivers Value, Growth, and Strategic Advantage · July 9, 2026 · 23 min

Explore listener stats, chart rankings, contacts and more on the Answers from the Lab podcast page.